Indraprastha Medical Corporation Limited

NSEI:INDRAMEDCO Stock Report

Market Cap: ₹44.9b

Indraprastha Medical Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Shivakumar Pattabhiraman

Chief executive officer

₹26.3m

Total compensation

CEO salary percentage96.0%
CEO tenure5.1yrs
CEO ownershipn/a
Management average tenure5.1yrs
Board average tenure5.1yrs

Recent management updates

We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned

Sep 18
We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned

We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Sep 15
We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Recent updates

The Trend Of High Returns At Indraprastha Medical (NSE:INDRAMEDCO) Has Us Very Interested

Dec 03
The Trend Of High Returns At Indraprastha Medical (NSE:INDRAMEDCO) Has Us Very Interested

Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Oct 14
Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned

Sep 18
We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 30
Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Aug 11
Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward

Aug 08
Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward

Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital

Jun 12
Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital

Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth

Apr 06
Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth

Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E

Feb 01
Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E

Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention

Nov 03
Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention

We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Sep 15
We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair

Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00

Sep 10
Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00

Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's

Aug 27
Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's

Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year

Aug 08
Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Jul 31
Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation

Jan 21
Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation

We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve

Nov 12
We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Nov 02
Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

May 12
Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)

Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Jun 10
Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)

Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year

Feb 21
Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year

CEO Compensation Analysis

How has Shivakumar Pattabhiraman's remuneration changed compared to Indraprastha Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024₹26m₹25m

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹964m

Mar 31 2023₹24m₹23m

₹862m

Dec 31 2022n/an/a

₹815m

Sep 30 2022n/an/a

₹765m

Jun 30 2022n/an/a

₹635m

Mar 31 2022₹26m₹26m

₹586m

Dec 31 2021n/an/a

₹585m

Sep 30 2021n/an/a

₹546m

Jun 30 2021n/an/a

₹430m

Mar 31 2021₹12m₹11m

₹23m

Dec 31 2020n/an/a

-₹63m

Sep 30 2020n/an/a

-₹76m

Jun 30 2020n/an/a

₹99m

Mar 31 2020₹25m₹10m

₹436m

Compensation vs Market: Shivakumar's total compensation ($USD309.49K) is about average for companies of similar size in the Indian market ($USD265.19K).

Compensation vs Earnings: Shivakumar's compensation has been consistent with company performance over the past year.

CEO

Shivakumar Pattabhiraman (58 yo)

5.1yrs

Tenure

₹26,294,567

Compensation

Mr. Shivakumar Pattabhiraman, B Com ACA Grad., CWA, serves as Managing Director and Additional Director of Indraprastha Medical Corporation Limited since November 5, 2019. He served as a Chief Financial an...

Leadership Team

NamePositionTenureCompensationOwnership
Shivakumar Pattabhiraman
MD & Additional Director5.1yrs₹26.29mno data
Chander Tyagi
Chief Financial Officer6.5yrs₹15.20mno data
Priya Ranjan
Company Secretary & Compliance Officer4.3yrs₹9.00mno data

5.1yrs

Average Tenure

Experienced Management: INDRAMEDCO's management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Shivakumar Pattabhiraman
MD & Additional Director5.1yrs₹26.29mno data
Vineeta Rai
Independent Non-Executive Director10.1yrs₹2.03m0%
₹ 0
Vinayak Chatterjee
Independent Non-Executive Director8.7yrs₹1.95mno data
Prathap Reddy
Non-Executive Vice Chairmanno data₹1.43m0.26%
₹ 116.3m
Madhumita Ganguli
Independent Director5.4yrs₹1.43mno data
Sangita Reddy
Non-Executive Director4.3yrs₹1.73m0.011%
₹ 4.9m
Suneeta Reddy
Non-Executive Director19.3yrs₹1.95m0.15%
₹ 67.8m
Salil Singhal
Independent Non-Executive Director3.8yrs₹1.35mno data
Mahesh Verma
Non-Executive Director3.8yrs₹1.65mno data
Arun Rai
Independent Director9.6yrs₹1.80mno data
Menaka Guruswamy
Independent Non-Executive Woman Director4.6yrs₹1.58mno data
Sandeep Somany
Directorless than a yearno datano data

5.1yrs

Average Tenure

65yo

Average Age

Experienced Board: INDRAMEDCO's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Indraprastha Medical Corporation Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ranjit KapadiaCentrum Broking Limited
Kameswari V. S. ChavaliFirstCall Research